And Sarit Polsky, MD, MPH, who was not involved with the current study, agrees that "AID with CamAPS, which has an option to customize the glucose target in the pregnancy-specific range, appears to be safe and effective in pregnancy and should be offered" to patients in Europe and the UK.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045